tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Parry, 7 are a BUY (43.75%), 7 are a HOLD (43.75%), 2 are a SELL (12.5%).
Analyst Graham Parry, currently employed at BAML, carries an average stock price target met ratio of 72.22% that have a potential upside of 63.15% achieved within 2507 days.
Graham Parry’s has documented 24 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 11-Sep-2024.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 10/4/2023. The price target of $115.47 was fulfilled within 617 days with a profit of $28.78 (33.2%) receiving and performance score of 0.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Feb-2025
Buy Since 08-Nov-2023
$41
$-11.5 (-21.90%)
$20.29
What Year was the first public recommendation made by Graham Parry?
